Photodynamic Therapy With S-1 in the Patients With Unresectable Type III or IV Cholangiocarcinoma: A Prospective Randomized Trial With Open Label Control.

Trial Profile

Photodynamic Therapy With S-1 in the Patients With Unresectable Type III or IV Cholangiocarcinoma: A Prospective Randomized Trial With Open Label Control.

Completed
Phase of Trial: Phase III

Latest Information Update: 30 Jan 2014

At a glance

  • Drugs Gimeracil/oteracil/tegafur (Primary) ; Porfimer sodium
  • Indications Cholangiocarcinoma
  • Focus Therapeutic Use
  • Most Recent Events

    • 30 Jan 2014 Status changed from recruiting to completed, based on publication of results.
    • 30 Jan 2014 Results published in the European Journal of Cancer.
    • 11 Mar 2013 Planned number of patients changed from 55 to 45 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top